Adaptive Biotechnologies Corp Research And Development Expense

• Adaptive Biotechnologies Corp showed a decrease of -8.9% in Research And Development Expense from 2024 to 2025.
• This data is from Adaptive Biotechnologies Corp's annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Adaptive Biotechnologies Corp's Research And Development Expense has grown by 193.1%.
• Historical annual values: Fiscal year 2025: $93.77 million | Fiscal year 2024: $102.95 million | Fiscal year 2023: $122.12 million | Fiscal year 2022: $141.76 million | Fiscal year 2021: $142.34 million | Fiscal year 2020: $116.07 million | Fiscal year 2019: $70.71 million | Fiscal year 2018: $39.16 million | Fiscal year 2017: $32.00 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026